论文部分内容阅读
About 75%of all breast cancers are estrogen receptor(ER)-positive.They generally have a more favorable clinical behavior,prognosis,and pattern of recurrence,and endocrine therapy forms the backbone of treatment.Anti-estrogens(such as tamoxifen and fulvest